Karen S. Gustafson joins the Pathology Department at Fox Chase Cancer Center
Philadelphia (July 7, 2009) – Karen S. Gustafson, MD, PhD, joined the Pathology Department at Fox Chase Cancer Center as a staff pathologist. Specializing in cytopathology, Gustafson uses her expertise to screen for and diagnose several types of cancer based on samples obtained through minimally invasive procedures, including fine needle aspiration biopsy and the Pap test.
“I chose Fox Chase so that I could be part of an institution that focuses on cancer patient care and research,” says Gustafson. “Expert pathologists within the Department of Pathology work closely with each other and with clinical and research colleagues to accomplish this goal.”
Gustafson’s clinical expertise is in cytopathology, where she evaluates cells and small tissue samples obtained using minimally invasive procedures such as fine needle aspiration biopsies. As a cytopathologist, Gustafson plays a key role in the multi-disciplinary patient care team, particularly in the areas of cancer screening and early diagnosis.
“My research interests are in the areas of cancer epigenetics and molecular biomarker development using cytologic samples,” Gustafson adds. “The Keystone Programs in Epigenetics and Stem Cell Progenitors and Personalized Risk and Prevention at Fox Chase provide unique opportunities for research collaborations.”
Prior to her arrival at Fox Chase, Gustafson was an assistant professor of pathology at The Johns Hopkins University School of Medicine and cytopathologist at The Johns Hopkins Hospital.
Gustafson earned her MD and PhD in Biomedical Sciences from the University of Minnesota Medical Scientist Training Program in Minneapolis, Minnesota in 1998. She went on to complete her residency in Anatomic and Clinical Pathology, Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania in 2002.
Her initial fellowship was completed in surgical pathology in 2003 in the Department of Pathology and Laboratory Medicine at the Hospital of the University of Pennsylvania. In 2004, Gustafson finished her second fellowship in cytopathology, at the Hospital of the University of Pennsylvania.
Gustafson is certified by the American Board of Pathology in cytophathology, anatomic pathology and clinical pathology. She is an active member of the College of American Pathologists; United States and Canadian Academy of Pathology; Papanicolaou Society of Cytopathology; and American Society of Cytopathology.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy6 Moore at 215-728-2700.